Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma by Seema Chugh, Jean C. Tien, Jennifer Hon, Carson Kenum, Rahul Mannan, Yunhui Cheng, Chi Chiang Li, Zainab I. Taher, Andrew D. Delekta, Pushpinder Singh Bawa, Ingrid J. Apel, Stephanie J. Miner, Xuhong Cao, Rohit Mehra, Saravana M. Dhanasekaran, Yuanyuan Qiao, Rajen Mody, Arul M. Chinnaiyan

Get full text

State-of-the art of endoscopic semeiology of neuroendocrine tumors of the stomach by I. B. Perfil’yev, V. V Delektorskaya, Yu. P. Kuvshinov, B. K. Poddubny, G. V. Ungiadze, S. S. Pirogov, O. A. Malikhova

Get full text